This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Lineage Cell Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Stephanie Kayser
Introduction
Stephanie Kayser is a prominent inventor based in Mountain View, CA (US). She has made significant strides in the field of stem cell research, particularly in the differentiation of pluripotent stem cells. Her work has implications for regenerative medicine and the treatment of various neurological conditions.
Latest Patents
Stephanie Kayser holds a patent for "Methods for differentiating pluripotent stem cells in dynamic suspension culture." This patent outlines methods for differentiating pluripotent stem cells to neuroectoderm using small molecule or protein inhibitors of TGFβ/Activin/Nodal signaling and BMP signaling. The methods described in her patent enable the reproducible production of neuroectoderm progenitor cells by day 7, glial progenitor cells by day 21, and oligodendrocyte progenitor cells (OPCs) by day 42 of the differentiation process.
Career Highlights
Kayser is currently associated with Lineage Cell Therapeutics, Inc., where she continues her research and development efforts. Her innovative approaches have contributed to advancements in stem cell technology and its applications in medicine.
Collaborations
Stephanie collaborates with notable colleagues, including Rekha R Nair and Abhirath S Parikh, who share her commitment to advancing scientific knowledge in the field of stem cell research.
Conclusion
Stephanie Kayser's contributions to the field of stem cell differentiation are noteworthy and reflect her dedication to innovation in medical science. Her patent and ongoing work at Lineage Cell Therapeutics, Inc. position her as a key figure in the advancement of regenerative medicine.